Cinctive Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.52M | Buy |
42,944
+40,956
| +2,060% | +$6.21M | 0.34% | 93 |
|
|
2025
Q1 | $299K | Sell |
1,988
-10,264
| -84% | -$1.54M | 0.02% | 275 |
|
|
2024
Q4 | $2.26M | Buy |
+12,252
| New | +$2.26M | 0.12% | 197 |
|
|
2024
Q2 | – | Sell |
-21,329
| Closed | -$5.78M | – | 394 |
|
|
2024
Q1 | $5.78M | Buy |
+21,329
| New | +$5.78M | 0.27% | 110 |
|
|
2023
Q2 | – | Sell |
-25,844
| Closed | -$5.22M | – | 367 |
|
|
2023
Q1 | $5.22M | Buy |
25,844
+13,427
| +108% | +$2.71M | 0.17% | 182 |
|
|
2022
Q4 | $2.71M | Buy |
+12,417
| New | +$2.71M | 0.13% | 217 |
|